plasma

1. August 30, 2021

   Study: Survivors’ plasma of no benefit to new COVID-19 patients

   A new study authored by a U-M researcher found that COVID-19 convalescent plasma did not prevent disease progression in an at-risk group of COVID patients when administered within one week of their symptoms.

2. October 5, 2020

   Lab-on-a-chip can quickly identify best plasma donors

   A new, portable lab-on-a-chip developed at U-M can identify the presence of COVID-19 antibodies in blood with greater speed and efficiency than the current standard ELISA technology.

3. July 30, 2020

   Michigan Medicine part of COVID-19 convalescent plasma trial

   Michigan Medicine is one of four U.S. medical centers recently awarded more than $7 million to study the role of convalescent plasma in mitigating symptoms of COVID-19 and preventing its progression.